21 – 30 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Quantifying AD-related brain amyloid with linearised progression models : model-based vs. data-based.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Rationale and design of the “NEurodegeneration : Traumatic brain injury as Origin of the Neuropathology (NEwTON)” study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy
(
- Contribution to journal › Article
-
Mark
Quantification of amyloid PET for future clinical use : a state-of-the-art review
(
- Contribution to journal › Scientific review
-
Mark
The natural history of primary progressive aphasia : beyond aphasia
(
- Contribution to journal › Article
-
Mark
Genetically identical twins show comparable tau PET load and spatial distribution
(
- Contribution to journal › Article
-
Mark
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals
(
- Contribution to journal › Article
- 2021
-
Mark
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
(
- Contribution to journal › Article
-
Mark
Biomarker testing in MCI patients—deciding who to test
(
- Contribution to journal › Article
-
Mark
Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups
(
- Contribution to journal › Article
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
(
- Contribution to journal › Article